CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Flexion Therapeutics

Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on the discovery, development & commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions. Flexion is based in Burlington, Massachusetts.

Nightengale Home Healthcare Inc

Nightengale Home Healthcare Inc is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MPLN, Molecular Pathology Laboratory Network

Personalized Molecular Pathology Laboratory Services Molecular Pathology Laboratory Network, Inc (MPLN) is a regional diagnostic laboratory specializing in oncology and women's health testing.

Ninos Latinos Unidos

Ninos Latinos Unidos is a Colton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ClearCorrect

ClearCorrect works with more than 14,000 doctors, making it a leading manufacturer of clear aligners. The company offers a more affordable and doctor-friendly approach, including a phase-based system to enhance flexibility and control for doctors. It just recently celebrated its 7th year anniversary and has international plans on the horizon.